TB-500 Safe is an independent editorial project that summarizes the peer-reviewed research on TB-500 and Thymosin Beta-4. We welcome editorial correspondence.
If you have found a citation error — a wrong DOI, a misquoted study result, or a broken PubMed link — please let us know. Getting the record right is the site's core purpose.
What we can and cannot respond to
We respond to: editorial corrections and citation disputes; questions about what a specific study found or how we interpreted it; new peer-reviewed research we may have missed.
We cannot respond to: requests for medical advice or dosing guidance; requests for sourcing or vendor recommendations; questions about individual health decisions. This site does not provide any clinical, medical, or pharmaceutical services. The about page explains the editorial scope in detail.
Send a message
Use the form below to reach the editorial team. Messages about TB-500 research updates and citation corrections receive priority.